14 November 2017

Last Saturday our highly appreciated colleague and friend Jasmijn Vogels - van Kampen passed away.

Jasmijn worked as PhD candidate since 2013 at the research laboratory of the department of Urology. She was an enthusiastic researcher who constantly tried to shift the boundaries of our insights into the behavior of malignant cells.

A year ago she was confronted with the "Emperor of All Maladies." She fought like a brave lioness to overcome this disease, unfortunately in vain. She had to deal with several setbacks, but she always stayed positive and kept in touch with her friends and colleagues. When she had to give up the battle  last week, together with her husband Rob, she came to RIMLS to say farewell to her lab-mates. A valuable and intimate moment. A few days later she died  at the age 27 years .

Jasmijn enjoyed life inside and outside the laboratory. She had a close relationship with her lab buddies, with whom she engaged in many (non science) extracurricular activities. She had found a very good balance between doing serious research and enjoying life.

We wish Rob, her family and her friends a lot of love and strength to give Jasmijn's loss a place.
 
On behalf of the Department of Urology,
Gerald Verhaegh and Jack Schalken
 

Related news items


New NFU eBROK® course open for registration

1 November 2019

This platform is not only for researchers who want to obtain their BROK® certificate, but also for researchers who already have a BROK® certificate and want to keep their certification (re-certification).

read more

A personal touch of Marlies Cornelissen

31 October 2019

In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Marlies Cornelissen.

read more

Collective cancer invasion forms an integrin-dependent radioresistant niche

29 October 2019

Anna Häger and Peter Friedl, theme Cancer development and immune defense, identified a new niche of cancer cell survival and developed an integrin inhibition therapy to overcome resistance. They have published their results in JEM.

read more

Algorithm to predict which cancer patients benefit from immunotherapy

29 October 2019

Rik Lindeboom and Michiel Vermeulen, theme Cancer development and immune defense, have developed an algorithm that can predict which cancer patients are more likely to benefit from immunotherapy. This new technology’s potential is described in Nature Genetics.

read more

X² Ambition Award for Sandra Heskamp

28 October 2019

This award is intended for 'coming women’: young, ambitious women at a stage of their careers where they make important career choices. This prize is especially for women who show exemplary behaviour within the organization where they work, but also outside their organization.

read more

A personal touch of Mariya Chernyavska

24 October 2019

In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Mariya Chernyavska.

read more